{"id":4821,"date":"2011-09-30T13:30:43","date_gmt":"2011-09-30T13:30:43","guid":{"rendered":"http:\/\/i-base.info\/qa\/?p=4821"},"modified":"2011-09-30T13:30:43","modified_gmt":"2011-09-30T13:30:43","slug":"can-my-partner-in-the-uk-switch-from-triomune","status":"publish","type":"post","link":"https:\/\/i-base.info\/qa\/4821","title":{"rendered":"Can my partner in the UK switch from Triomune?"},"content":{"rendered":"<p>Hi<\/p>\n<p>Your partner is getting good advice from this doctor. Stavudine (also called d4T) has not been widely used in the UK for well over five years becasue of the increased risk of a range of side effects.<\/p>\n<p>If everything else is going well, the easiest option would be to continue taking nevirapine (one of the other drugs in Triomune).<\/p>\n<p>The new drugs would then be either Truvada (tenofovir+FTC) or Kivexa (abacavir\/3TC), each of which only requires one pill once-daily. Which one of these will depend on your partners treatment history and the result of other tests.<\/p>\n<p>Several other options are available including using efavirenz but the first options above will probably be discussed first.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>My partner has been taking Triomune-30 since Jan 2011 after a CD4 count of 135.<\/p>\n<p>After additional tests in the UK and a CD4 count of 153 and viral load of 133, the doctor wants to recommend a new drug because they said the UK doesnt prescribe stavudine.<\/p>\n<p>Is it ok to change meds and what are the likely effects of that? Also do u know what the medication is likely to be?<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,10],"tags":[],"class_list":["post-4821","post","type-post","status-publish","format-standard","hentry","category-all-topics","category-changing-treatment"],"_links":{"self":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/4821","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/comments?post=4821"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/posts\/4821\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/media?parent=4821"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/categories?post=4821"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/qa\/wp-json\/wp\/v2\/tags?post=4821"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}